{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:43:51Z","timestamp":1789753431954,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007515","name":"National Natural Science Foundation for Youths","doi-asserted-by":"crossref","award":["81601912"],"award-info":[{"award-number":["81601912"]}],"id":[{"id":"10.13039\/100007515","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["81660365"],"award-info":[{"award-number":["81660365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bbrc.2018.11.201","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T07:55:07Z","timestamp":1544255707000},"page":"902-906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-\u03baB and MAPK signaling pathways"],"prefix":"10.1016","volume":"508","author":[{"given":"Qiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.11.201_bib1","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2018.11.201_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.NPR.0000352286.81981.0e","article-title":"Pharmacotherapeutic management of osteoprosis and osteopenia","volume":"34","author":"Alexander","year":"2009","journal-title":"Nurs. Pract."},{"key":"10.1016\/j.bbrc.2018.11.201_bib3","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2018.11.201_bib4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/BLO.0b013e31804b4147","article-title":"The biology of aseptic osteolysis","volume":"460","author":"Holt","year":"2007","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bbrc.2018.11.201_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0167-5699(00)01718-7","article-title":"Osteoprotegerin ligand: a regulator of immune responses and bone physiology","volume":"21","author":"Kong","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.bbrc.2018.11.201_bib6","first-page":"1325","article-title":"Interaction between osteoblast and osteoclast: impact in bone disease","volume":"19","author":"Phan","year":"2004","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.bbrc.2018.11.201_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.11.201_bib8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.tem.2012.05.005","article-title":"New insights into osteoclastogenic signaling mechanisms","volume":"23","author":"Nakashima","year":"2012","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2018.11.201_bib9","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/jc.2013-1597","article-title":"The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension","volume":"98","author":"Bone","year":"2013","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2018.11.201_bib10","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1007\/s00586-003-0622-z","article-title":"Bisphosphonates in osteoporosis","volume":"12","author":"Fleisch","year":"2003","journal-title":"Eur. Spine J."},{"key":"10.1016\/j.bbrc.2018.11.201_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2018.11.201_bib12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ptr.5027","article-title":"Icariin: does it have an osteoinductive potential for bone tissue engineering?","volume":"28","author":"Zhang","year":"2014","journal-title":"Phytother Res."},{"key":"10.1016\/j.bbrc.2018.11.201_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jep.2016.05.025","article-title":"Traditional Chinese medicine formulas for the treatment of osteoporosis: implication for antiosteoporotic drug discovery","volume":"189","author":"Zhang","year":"2016","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.bbrc.2018.11.201_bib14a","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/jcp.24158","article-title":"Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling","volume":"228","author":"Ming","year":"2013","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.bbrc.2018.11.201_bib14b","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00198-017-4255-1","article-title":"The effect of icariin on bone metabolism and its potential clinical application","volume":"29","author":"Wang","year":"2018","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bbrc.2018.11.201_bib14c","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.phymed.2008.12.006","article-title":"Antiosteoporotic activity of icariin in ovariectomized rats","volume":"16","author":"Nian","year":"2009","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbrc.2018.11.201_bib15","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1359\/jbmr.070405","article-title":"Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial","volume":"22","author":"Zhang","year":"2007","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.bbrc.2018.11.201_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jss.2014.05.038","article-title":"Inhibitory effect of icariin on Ti-induced inflammatory osteoclastogenesis","volume":"192","author":"Cui","year":"2014","journal-title":"J.\u00a0Surg. Res."},{"key":"10.1016\/j.bbrc.2018.11.201_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.nutres.2009.10.020","article-title":"Icariin protects murine chondrocytes from lipopolysaccharide-induced inflammatory responses and extracellular matrix degradation","volume":"30","author":"Liu","year":"2010","journal-title":"Nutr. Res."},{"key":"10.1016\/j.bbrc.2018.11.201_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejphar.2010.05.012","article-title":"Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K\/Akt and NF-kappaB signaling pathway","volume":"642","author":"Xu","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.11.201_bib19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fphar.2017.00627","article-title":"The beneficial effect of praeruptorin C on osteoporotic bone in ovariectomized mice via suppression of osteoclast formation and bone resorption","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.11.201_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1196\/annals.1402.071","article-title":"The role of NFAT in osteoclast formation","volume":"1116","author":"Takayanagi","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2018.11.201_bib21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbrc.2018.11.201_bib22","doi-asserted-by":"crossref","first-page":"18245","DOI":"10.1074\/jbc.M610701200","article-title":"NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1","volume":"282","author":"Yamashita","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.11.201_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078612","article-title":"Polyphosphate-mediated inhibition of tartrate-resistant acid phosphatase and suppression of bone resorption of osteoclasts","volume":"8","author":"Harada","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.bbrc.2018.11.201_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jmb.2008.07.038","article-title":"The crystal and molecular structures of a cathepsin K: chondroitin sulfate complex","volume":"383","author":"Li","year":"2008","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.bbrc.2018.11.201_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i3.40","article-title":"Bone modeling and remodeling","volume":"19","author":"Seeman","year":"2009","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.bbrc.2018.11.201_bib26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/odi.12624","article-title":"Regulation of bone remodeling by vitamin K2","volume":"23","author":"Myneni","year":"2017","journal-title":"Oral Dis."},{"key":"10.1016\/j.bbrc.2018.11.201_bib27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.14348\/molcells.2014.0153","article-title":"A\u00a0medium-chain fatty acid, capric acid, inhibits RANKL-induced osteoclast differentiation via the suppression of NF-kappaB signaling and blocks cytoskeletal organization and survival in mature osteoclasts","volume":"37","author":"Kim","year":"2014","journal-title":"Mol. Cell."},{"key":"10.1016\/j.bbrc.2018.11.201_bib28","doi-asserted-by":"crossref","first-page":"35081","DOI":"10.1074\/jbc.C500353200","article-title":"Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1","volume":"280","author":"Monje","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.11.201_bib29","doi-asserted-by":"crossref","first-page":"45969","DOI":"10.1074\/jbc.M408795200","article-title":"Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1","volume":"279","author":"Matsumoto","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.11.201_bib30","doi-asserted-by":"crossref","first-page":"32905","DOI":"10.1074\/jbc.M505820200","article-title":"Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis","volume":"280","author":"Kim","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.11.201_bib31","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1074\/jbc.274.12.7724","article-title":"Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif","volume":"274","author":"Darnay","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.11.201_bib32","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/MCB.21.7.2475-2484.2001","article-title":"Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway","volume":"21","author":"Takaesu","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2018.11.201_bib33","first-page":"153","article-title":"Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions","volume":"22","author":"Pearson","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbrc.2018.11.201_bib34","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s00198-013-2313-x","article-title":"NF-\u03baB signaling and bone resorption","volume":"24","author":"Abu-Amer","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bbrc.2018.11.201_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch. Biochem. Biophys."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18326391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18326391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:04:09Z","timestamp":1605571449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18326391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0006291X18326391"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.11.201","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-\u03baB and MAPK signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.11.201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}